Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 151–176 of 176 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06679920	Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment(BLOCT)	recruiting	N/A	15	Amsterdam UMCOTHER	1	Dec 6, 2024	clinicaltrials
NCT06016075	Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques(IBM-Renal)	recruiting	N/A	30	University of CambridgeOTHER	1	Dec 5, 2024